Nanjing F&S Pharmatech Co.

PharmaceuticalsSeries BNanjing, Chinafshpharm.com

Latest round

Series B

Last raised

Mar 2020

Total raised

$16M

Investors

8

About Nanjing F&S Pharmatech Co.

, Ltd. is a developer and manufacturer of differentiated API, KSM and pharmaceutical intermediates based on chemical technology.

Who invested in Nanjing F&S Pharmatech Co.

8 investors across 3 rounds

See all investors in Nanjing F&S Pharmatech Co.

Sign up free to see every VC on the cap table, the rounds they joined, and how much each round raised.

Funding rounds

  1. Series B

    Mar 20, 2020

    Amount

    $8.9M

    Investors

    Locked

  2. Series A

    Sep 30, 2018

    Amount

    $7.3M

    Investors

    Locked

  3. Series A

    May 3, 2018

    Amount

    Undisclosed

    Investors

    Locked

Questions about Nanjing F&S Pharmatech Co.

Who invested in Nanjing F&S Pharmatech Co.?

Nanjing F&S Pharmatech Co. has 8 investors on record across 3 venture rounds. Sign up free to see every VC on the cap table and the rounds they joined.

How much funding has Nanjing F&S Pharmatech Co. raised?

Nanjing F&S Pharmatech Co. has raised 3 venture rounds. Sign up free to see how much each round raised and the total.

When did Nanjing F&S Pharmatech Co. last raise money?

Nanjing F&S Pharmatech Co.'s most recent round on record is a Series B, in Mar 2020.

What does Nanjing F&S Pharmatech Co. do?

Nanjing F&S Pharmatech Co. is a pharmaceuticals company.

Where is Nanjing F&S Pharmatech Co. headquartered?

Nanjing F&S Pharmatech Co. is headquartered in Nanjing, China.

Which VCs invest in companies like Nanjing F&S Pharmatech Co.?

Among active investors with capital left to deploy, Shanghai State-owned Capital Investment Leading Fund, Yufu Capital, ICBC Capital Management and Ningbo Tongshang Fund back pharmaceuticals companies at Nanjing F&S Pharmatech Co.'s stage. Their profiles are linked below.

Raising like Nanjing F&S Pharmatech Co.? Find the right VCs.

Capital Atlas matches your startup to active investors by stage, sector and region.

Free to start. Upgrade when you're ready to reach out.